Prevalence of SP cells in bone marrow and peripheral blood specimens of patients with AML.

The results are reported as percentages of viable MNCs per sample and were grouped according to the patients' disease stage (untreated, in complete hematological remission, or relapsed/resistant). Horizontal bars indicate median values.